| Trial ID: | L2566 |
| Source ID: | NCT02015910
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02015910/results
|
| Conditions: |
Type II Diabetes
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Percent Wounds Healed, Compare the rate of healing as well as percent of wounds healed in Type II diabetic patients with chronic foot ulcerations receiving sitagliptin versus placebo., 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Georgetown University | Collaborators: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
1
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-01
|
| Completion Date: |
2015-01
|
| Results First Posted: |
2017-01-06
|
| Last Update Posted: |
2017-01-06
|
| Locations: |
Medstar Georgetown University Hospital, Washington, District of Columbia, 20007, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02015910
|
